pharma news today obesity drugs glp-1 october 2025 Market 2024 was a record year

See how RYBELSUS performed in the PIONEER 3 Trial

Buy Retatrutide Canada (120 mg) for research involving triple-agonist metabolic pathways, energy regulation, and adipose signaling

Doctor-developed bundle cultivating targeted restoration across the Gut-Metabolic Axis: GLP-1 boosting + Weight Support + Digestive Support + Heart and Circulatory Support + Caffeine-Free Energy

Heres what to watch as this $40B+ category continues to grow.

We measure the odds ratio of developing pancreatitis between patients who have taken a large cumulative dose of GLP-1 agonist and those with a low cumulative dose of GLP-1 agonist

At Pendulum, were passionate about finding revolutionary, safe, and effective solutions to the ailments that can be tied to our gut health